Hair loss discussion includes treatments Minoxidil, Finasteride, and RU58841. Prolactin's role in immunesystem's antitumor activity raises safety concerns for HMI-115.
COVID and COVID vaccination can trigger hair loss, primarily telogen effluvium, due to stress and immunesystem activation. Proper diagnosis and addressing factors like nutrition and stress are crucial for recovery.
The conclusion of the conversation is that the user "Shakalakaplaka" shares their comprehensive hair loss regimen, which includes various treatments targeting different pathways such as DHT, inflammation, fibrosis, immunesystem, testosterone, gut problems, and scalp health. The effectiveness of the regimen is not confirmed, and some users express skepticism or request before and after pictures for credibility.
The conversation is about whether it is safe to take Xeljanz, a JAK inhibitor, while also taking finasteride for hair loss. The concern is that Xeljanz weakens the immunesystem, which could be risky.
Concerns about the potential systemic effects and safety of PP405 for hair loss, with discussions on its comparison to existing treatments like finasteride and minoxidil. Users express skepticism about untested research chemicals and emphasize the importance of clinical trials to ensure safety and efficacy.